Home Stock

Stock Research: NeoGenomics

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

NeoGenomics

NAQ:NEO US64049M2098
54
  • Value
    26
  • Growth
    35
  • Safety
    Safety
    64
  • Combined
    22
  • Sentiment
    79
  • 360° View
    360° View
    54
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. It offers comprehensive oncology-focused testing menus and services including clinical cancer testing, molecular and NGS testing, clinical trials and research, and oncology data solutions. The company operates laboratories across the United States and in Cambridge, United Kingdom. In the last fiscal year, the company had a market cap of $900 million, profits of $290 million, revenue of $661 million, and 2200 employees.

more

ANALYSIS: With an Obermatt 360° View of 54 (better than 54% compared with alternatives), overall professional sentiment and financial characteristics for the stock NeoGenomics are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for NeoGenomics. The consolidated Sentiment Rank has a good rank of 79, which means that professional investors are more optimistic about the stock than for 79% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 64 or better than 64% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 26, meaning that the share price of NeoGenomics is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 35. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Refinancing
Country USA
Industry Health Care Services
Size Medium
Website neogenomics.com
Index
NASDAQ
NeoGenomics stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
26 27 37 51
Growth
35 63 91 9
Safety
Safety
64 46 28 60
Sentiment
79 41 84 59
360° View
360° View
54 33 75 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
23 75 74 74
Opinions Change
50 40 50 50
Pro Holdings
n/a 13 73 67
Market Pulse
67 38 52 18
Sentiment
79 41 84 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
26 27 37 51
Growth
35 63 91 9
Safety Safety
64 46 28 60
Combined
22 38 61 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
44 45 41 64
Price vs. Earnings (P/E)
10 15 53 20
Price vs. Book (P/B)
75 61 54 68
Dividend Yield
1 1 1 1
Value
26 27 37 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
57 78 50 45
Profit Growth
27 84 98 4
Capital Growth
72 30 37 76
Stock Returns
36 35 95 25
Growth
35 63 91 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
64 46 36 46
Refinancing
93 54 48 65
Liquidity
11 26 22 37
Safety Safety
64 46 28 60

Similar Stocks

Discover high‑ranked alternatives to NeoGenomics and broaden your portfolio horizons.

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

FedEx

NYQ:FDX
Country: USA
Industry: Air Freight & Logistics
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews